Search
Monte Rosa Therapeutics Inc
GLUEAdd to Watchlist
16.520USD
-6.160-27.16%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.40BMarket Cap
LossP/E TTM
Monte Rosa Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Monte Rosa Therapeutics Inc is 9.09, ranking 31 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -11.15, which is -813.85% below the recent high of 79.61 and -304.58% above the recent low of -45.12.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.